Non-interventional, retrospective, multi-center, follow-up study evaluating the effect of the angiotensin II type 2 receptor agonist C21 on lung pathology in subjects previously hospitalised with COVID-19

Source: International Congress 2022 – COVID infections prognosis: risk factors and treatment

Session: COVID infections prognosis: risk factors and treatment
Session type: Thematic Poster
Number: 3377

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Batta (Stockholm, Sweden), G. Tornling (Stockholm, Sweden), T. Bengtsson (Stockholm, Sweden), A. Devaraj (London, United Kingdom), R. Kashiva (Pune, India), A. Rajkondawar (Nagpur, India), K. Parmar (Ahmedabad, India), N. Bhalani (Vododara, India), A. Bohra (Milton Keynes, United Kingdom), A. Cohrt (Stockholm, Sweden), C. Ganslandt (Stockholm, Sweden). Non-interventional, retrospective, multi-center, follow-up study evaluating the effect of the angiotensin II type 2 receptor agonist C21 on lung pathology in subjects previously hospitalised with COVID-19. 3377

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
• Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
• Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living